oncnursingnews12h
Amezalpat Receives FDA Fast Track Designation for Hepatocellular Carcinoma
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations
Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing ...
Targeted Oncology1d
FDA Fast Tracks Amezalpat for HCC Treatment
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
RTE Online1d
Revenues at Irish arm of pharma giant Roche rise by 7%
The directors of the Irish arm of pharma giant Roche have stated that there is a need to reduce the lengthy timelines to ...